Search This Blog

Monday, December 18, 2023

NTx: FDA Clearance of its Investigational New Drug (IND) Application for UTIs

 

  • "Study May Proceed" letter received from FDA

  • Potential to initiate registrational study in 2024

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)